Literature DB >> 66473

Neocortical cholinergic neurons in elderly people.

P White, C R Hiley, M J Goodhardt, L H Carrasco, J P Keet, I E Williams, D M Bowen.   

Abstract

Choline acetyltransferase activity (presynaptic cholinergic system) and high affinity binding of cholinergic antagonists (postsynaptic cholinergic system) were measured in brain tissue removed after death from both mentally normal and demented old people. Muscarinic receptor binding sites in frontal cortex decreased with advancing years only in old people without appreciable morphological evidence of senile degeration. Preliminary data for temporal lobe suggested that also in Pick's disease the density of receptor binding sites is reduced. The markers are not significantly reduced in cases of mixed senile and vascular dementia. However, in non-vascular senile dementia of the Alzheimer type, there were indications that the presynaptic marker is selectively depleted. Therefore, centrally acting anticholinesterases might be beneficial, particularly in the early stages of the disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66473     DOI: 10.1016/s0140-6736(77)92114-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  57 in total

Review 1.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  Serge Gauthier
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

Review 2.  Biochemistry of Dementias.

Authors:  D M Bowen
Journal:  Proc R Soc Med       Date:  1977-05

Review 3.  Depression in the elderly: the role of the primary care physician in management.

Authors:  J F McGreevey; K Franco
Journal:  J Gen Intern Med       Date:  1988 Sep-Oct       Impact factor: 5.128

4.  A meta-analysis of the effects of aging on motor cortex neurophysiology assessed by transcranial magnetic stimulation.

Authors:  Apoorva Bhandari; Natasha Radhu; Faranak Farzan; Benoit H Mulsant; Tarek K Rajji; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Clin Neurophysiol       Date:  2016-06-08       Impact factor: 3.708

5.  Trial of levodopa in senile dementia.

Authors:  C Lewis; B R Ballinger; A S Presly
Journal:  Br Med J       Date:  1978-03-04

6.  A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.

Authors:  A Little; R Levy; P Chuaqui-Kidd; D Hand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

Review 7.  Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment.

Authors:  C G Gottfries
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Evidence for an increased rate of choline efflux across erythrocyte membranes in Alzheimer's disease.

Authors:  D A Butterfield; M M Nicholas; W R Markesbery
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

9.  A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

10.  Substantia innominata: MR findings in Parkinson's disease.

Authors:  Hirobumi Oikawa; Makoto Sasaki; Shigeru Ehara; Takashi Abe
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.